urea
FDA Approved
Description
Urea is a keratolytic agent used topically to treat hyperkeratotic skin conditions. It works by hydrating and softening the stratum corneum, promoting desquamation of scaly skin. Urea preparations are commonly used for various keratotic disorders including focal acral hyperkeratosis.
Indications & Therapeutic Use
hyperkeratosis, ichthyosis, keratosis pilaris, dry skin conditions
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
urea
| Generic Name | urea |
| Brands | 1 brand available |
| Active Ingredient | urea |
| Drug Class | hyperkeratosis |
| Manufacturer | Various |
| Dosage Forms | topical cream 10%, 20%, 40%; lotion; ointment |
| Medical Code | D02AE01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes